UGT8 and neuropathy: In this study, targeted mass spectrometry showed that GalCer levels were significantly decreased in the PDPN group, and similarly, Western blot and qPCR showed that its synthase Ugt8 was expressed at a reduced level in the PDPN group, highlighting the role of GalCer in driving DPN neuropathy.